University Of Southampton And Inovio Pharmaceuticals Initiate Phase 2 Clinical
Study To Evaluate Leukemia
Main Category: Lymphoma / Leukemia / Myeloma
Also Included In: Clinical Trials / Drug Trials; Cancer / Oncology; Blood /
Hematology
Article Date: 31 Jan 2011 - 4:00 PST
Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of
therapeutic and preventive vaccines against cancers and infectious diseases,
announced today the regulatory approval of a Phase 2 clinical trial |